An international non-profit supporting antibody-related research and development.
PAIA Bio CEO Sebastian Giehring discusses PAIA Bio's Developability Assays during this on-demand webinar. Tune into this session to learn about this new technology for tackling current challenges in early developability assessments.
On February 13th, 2025, CEO of PAIA Bio Sebastian Giehring will join us to discuss PAIA Bio's Developability Assays. Join us to learn more about this new technology for tackling current challenges in early developability assessments.